Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions

被引:103
作者
Woodrum, D
French, C
Shamel, LB
机构
[1] Hybritech, Inc., San Diego, CA
[2] Hybritech, Inc., San Diego, CA 92196-9006
关键词
D O I
10.1016/S0090-4295(96)00607-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Four studies were conducted to characterize the stability of free and total prostate specific antigen (PSA) under various sample collection and storage conditions. Methods. In the first study, fresh blood from 11 patients was drawn and allowed to clot at room temperature (RT). Serum was prepared by centrifugation 1, 3, 5, or 8 hours after the blood draw and tested to determine the free and total PSA levels. In the second study, serum specimens from 12 individuals were stored at RT or 4 degrees C and were tested on days 0, 1, 2, and 7. In the third study, four fresh serum samples were subjected to five freeze-thaw cycles and tested after each cycle. In the fourth study, 29 fresh samples were aliquoted, frozen at -20 degrees C or -70 degrees C, and monitored for long-term stability. Results. Approximately 1% of the free PSA was lost per hour of clotting time. Between 2% and 5% of the free PSA was lost per day of storage at 4 degrees C or 23 degrees C. About 0.9% of the free PSA was lost per month of storage at -20 degrees C compared with about 0.4% per month at -70 degrees C. Total PSA appeared to be stable throughout these studies. Conclusions. Our results suggest that routine serum preparation and refrigerated storage of samples for up to 24 hours is acceptable for the measurement of both free and total PSA. Samples that are to be retained for longer than 24 hours should be frozen. Samples stored for extended periods should be kept at -70 degrees C. Copyright 1996 by Elsevier Science Inc.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 28 条
[1]  
Campo Richard, 1996, Journal of Urology, V155, p425A
[2]  
Catalona William J., 1995, JAMA (Journal of the American Medical Association), V274, P1214, DOI 10.1001/jama.274.15.1214
[3]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[4]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290
[5]  
CHEN ZX, 1995, CLIN CHEM, V41, P1273
[6]   SERUM PROSTATE-SPECIFIC ANTIGEN COMPLEXED TO ALPHA-1-ANTICHYMOTRYPSIN AS AN INDICATOR OF PROSTATE-CANCER [J].
CHRISTENSSON, A ;
BJORK, T ;
NILSSON, O ;
DAHLEN, U ;
MATIKAINEN, MT ;
COCKETT, ATK ;
ABRAHAMSSON, PA ;
LILJA, H .
JOURNAL OF UROLOGY, 1993, 150 (01) :100-105
[7]   ENZYMATIC-ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS REACTIONS WITH EXTRACELLULAR SERINE PROTEINASE-INHIBITORS [J].
CHRISTENSSON, A ;
LAURELL, CB ;
LILJA, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (03) :755-763
[8]  
Collins Gerald N., 1996, Journal of Urology, V155, p421A
[9]  
Franklin John, 1996, Journal of Urology, V155, p378A
[10]  
Herschman Jonathan D., 1996, Journal of Urology, V155, p423A